| | | | | |
AGIO Agios Pharmaceuticals, Inc. | €23,4720 | +2,74% | €1,50B | €157,79K | |
SGRY Surgery Partners, Inc. Common Stock | €11,7007 | -1,40% | €1,50B | €482,63K | |
GAB The Gabelli Equity Trust Inc. | €4,8304 | -0,27% | €1,50B | €455,45K | |
HURN Huron Consulting Group Inc. | €90,0400 | -2,00% | €1,50B | €78,79K | |
ENVX Enovix Corporation Common Stock | €7,1357 | -3,94% | €1,50B | €3,46M | |
PAYO Payoneer Global Inc. Common Stock | €4,2875 | -7,01% | €1,50B | €2,10M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | €12,8537 | -0,23% | €1,49B | €90,90K | |
STGW Stagwell Inc. Class A Common Stock | €5,7353 | -7,57% | €1,49B | €882,21K | |
CASH Pathward Financial, Inc. Common Stock | €68,0046 | -3,07% | €1,49B | €109,24K | |
SNDX Syndax Pharmaceuticals, Inc. | €15,9097 | +0,39% | €1,49B | €289,20K | |
STRA Strategic Education, Inc. Common Stock | €67,6384 | -0,85% | €1,49B | €40,44K | |
CAPR Capricor Therapeutics Inc | €23,5745 | +0,05% | €1,49B | €251,47K | |
AAPG Ascentage Pharma Group International American Depository Shares | €15,2573 | -4,04% | €1,49B | €13,25K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | €7,0280 | -2,10% | €1,49B | €4,33M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | €21,5795 | +3,13% | €1,49B | €74,64K | |
